ImageneBio Q2 EPS $(0.63) Beats $(1.05) Estimate
ImageneBio (NASDAQ:IMA) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(1.05) by 40 percent.
ImageneBio lost less money per share than experts thought it would—kind of like spending $63 instead of $105 of your allowance. When a company that's still losing money does better than people expected, it can show they're getting smarter about how they spend their cash.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.